Navigation Links
New role for DNA methylation in subset of premature aging disorder patients
Date:1/31/2013

Scientists at the Bellvitge Biomedical Research Institute in Barcelona, Spain have found new evidence for the role of epigenetic changes (those heritable alterations in gene expression caused by mechanisms other than changes in DNA sequence) on premature aging diseases. A new study published in the journal Epigenetics on Jan. 1, 2013, identified a role for DNA methylation changes in a subset of Hutchinson-Gilford Progeria and Werner Syndrome patients, for which no genetic cause (such as DNA mutation) had been associated with onset disease. The study, titled "Aberrant DNA methylation profiles in the premature aging disorders Hutinson-Gilford Progeria and Werner syndrome," is available at http://www.landesbioscience.com/journals/epigenetics/article/23366/.


'/>"/>

Contact: Barbara Rattner
barbara@landesbioscience.com
Landes Bioscience
Source:Eurekalert

Page: 1

Related medicine news :

1. As New Premature Ejaculation Drugs Get Closer To The Public Market, LastLonger2Night.com Announces A Drug-Free Solution
2. Phobic Anxiety May Link to Premature Aging
3. Survival rates for premature babies in high-level NICUs are better than previously reported
4. Cervical Disease Treatment Not Linked to Premature Birth Risk
5. $8.9 million NIH grant to study genomic link to premature heart disease
6. Simple test to predict if pregnant women will give birth prematurely
7. Self-Harm Associated With Premature Death in Study
8. Guidelines developed for extremely premature infants at NCH proven to be life-changing
9. Pregnant Women With Bipolar Disorder May Have Higher Risk of Premature Birth
10. Children born prematurely are at higher risk of esophageal inflammation, cancer
11. Study findings have potential to prevent,reverse disabilities in children born prematurely
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: